investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Validating Syk as a Target for AML Therapy

Kimberly Stegmaier

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

David A Scheinberg

Mechanisms of action of a TCR-like antibody to WT1

Leukaemia

Omar Abdel-Wahab

Role of ASXL1 mutations in myeloid malignancies

Leukaemia

Katerina V Gurova

Modulation of cancer specific transcriptional factors with small molecules

Leukaemia

Kim O'Neill

Cancer Immunology Research at Brigham Young University

Leukaemia

Arnav Mehta

MicroRNA-125b physiologically and pathologically regulates myelopoiesis through I

Leukaemia

Alan Rein

Interactions of APOBEC3 Proteins with Murine Leukemia Viruses

Leukaemia

Pathology Hematology and hematologic malignancies

Michael L Cleary

Role of PGDH in leukemia pathogenesis

Leukaemia

Carol Prives

Properties and Regulation of p53 in Tumor Cells

Leukaemia

Pathology

Honami Naora

Stromal Interactions and Leukemic Risk in Myelodysplastic Syndromes

Leukaemia